Catherine J. Harmer mainly focuses on Antidepressant, Mood, Clinical psychology, Facial expression and Psychiatry. Her Antidepressant research is multidisciplinary, incorporating perspectives in Drug action, Randomized controlled trial and Anxiety. Her Mood research includes themes of Functional magnetic resonance imaging and Affect.
Her Clinical psychology study combines topics from a wide range of disciplines, such as Schizophrenia, Cognition, Emotional bias, Meta-analysis and Depression. Her work carried out in the field of Facial expression brings together such families of science as Audiology, Developmental psychology, Neuroscience, Amygdala and Disgust. Her Psychiatry research includes elements of Emerging technologies and eHealth.
Her scientific interests lie mostly in Clinical psychology, Antidepressant, Psychiatry, Cognition and Depression. Her research in Clinical psychology is mostly concerned with Mood. Catherine J. Harmer works mostly in the field of Mood, limiting it down to concerns involving Audiology and, occasionally, Vigilance.
She interconnects Psychotherapist and Serotonin in the investigation of issues within Antidepressant. Her Cognition research is multidisciplinary, incorporating elements of Developmental psychology and Cognitive psychology. Her studies in Depression integrate themes in fields like Internal medicine, Randomized controlled trial and Attentional bias.
Her scientific interests lie mostly in Cognition, Clinical psychology, Depression, Neuroscience and Mood. She combines subjects such as Antidepressant, Prucalopride, Neuroimaging and Mood disorders with her study of Cognition. The Clinical psychology study combines topics in areas such as Facial expression, Exploratory factor analysis and Elementary cognitive task.
The study incorporates disciplines such as Neuropsychology, Functional connectivity, Attentional bias, Anxiety and Resting state fMRI in addition to Depression. Her Neuroscience study integrates concerns from other disciplines, such as Receptor and Partial agonist. Her study in Mood is interdisciplinary in nature, drawing from both Bipolar disorder, Functional neuroimaging and Cohort.
Her primary scientific interests are in Cognition, Mood, Neuroscience, Antidepressant and Clinical psychology. Her work in Cognition addresses subjects such as Neuroimaging, which are connected to disciplines such as MEDLINE, Mood disorders, Bioinformatics and Trait anxiety. The various areas that Catherine J. Harmer examines in her Mood study include Bipolar disorder, Functional magnetic resonance imaging, Prefrontal cortex, Beck Depression Inventory and Neural correlates of consciousness.
Her Antidepressant research is classified as research in Depression. Her Clinical psychology research incorporates themes from Confounding and Elementary cognitive task. Catherine J. Harmer has included themes like Internal medicine and Placebo-controlled study in her Anxiety study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.
Catherine J. Harmer;Nicholas C. Shelley;Philip J. Cowen;Guy M. Goodwin.
American Journal of Psychiatry (2004)
Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action
Catherine J. Harmer;Guy M. Goodwin;Philip J. Cowen.
British Journal of Psychiatry (2009)
Effect of Acute Antidepressant Administration on Negative Affective Bias in Depressed Patients
Catherine J Harmer;Ursula O'Sullivan;Elisa Favaron;Rachel Massey-Chase.
American Journal of Psychiatry (2009)
Antidepressant drug treatment modifies the neural processing of nonconscious threat cues.
Catherine J. Harmer;Clare E. Mackay;Catriona B. Reid;Philip J. Cowen.
Biological Psychiatry (2006)
Acute SSRI administration affects the processing of social cues in healthy volunteers.
C J Harmer;Z Bhagwagar;D I Perrett;B A Völlm.
Neuropsychopharmacology (2003)
Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers
Kristin Schmidt;Philip J. Cowen;Catherine J. Harmer;George Tzortzis.
Psychopharmacology (2015)
The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science
Emily A Holmes;Ata Ghaderi;Catherine J Harmer;Catherine J Harmer;Paul G Ramchandani.
The Lancet Psychiatry (2018)
Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment
Ciara McCabe;Zevic Mishor;Philip J. Cowen;Catherine J. Harmer.
Biological Psychiatry (2010)
How do antidepressants work? New perspectives for refining future treatment approaches
Catherine J Harmer;Ronald S Duman;Philip J Cowen.
The Lancet Psychiatry (2017)
Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity.
Catherine J. Harmer;Simon A. Hill;Matthew J. Taylor;Philip J. Cowen.
American Journal of Psychiatry (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Oxford
University of Oxford
Copenhagen University Hospital
University of Bristol
University of Copenhagen
University of Oxford
University of Copenhagen
University of Oxford
University of Bristol
University of Oslo
University of Pennsylvania
Hunan University
University of Granada
National Institutes of Health
United States Department of Agriculture
University of Lorraine
Yunnan University
University of Pittsburgh
United States Geological Survey
Boston University
University of Alabama at Birmingham
University of Toronto
National Institutes of Health
University of Zurich
Vrije Universiteit Amsterdam
University of Michigan–Ann Arbor